Literature DB >> 23022685

In-vitro investigation of out-of-field cell survival following the delivery of conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) plans.

Conor K McGarry1, Karl T Butterworth, Colman Trainor, Stephen J McMahon, Joe M O'Sullivan, Kevin M Prise, Alan R Hounsell.   

Abstract

The aim of this work is to determine the out-of-field survival of cells irradiated with either the primary field or scattered radiation in the presence and absence of intercellular communication following delivery of conformal, IMRT and VMAT treatment plans. Single beam, conformal, IMRT and VMAT plans were created to deliver 3 Gy to half the area of a T80 flask containing either DU-145 or AGO-1522 cells allowing intercellular communication between the in- and out-of-field cell populations. The same plans were delivered to a similar custom made phantom used to hold two T25 culture flasks, one flask in-field and one out-of-field to allow comparison of cell survival responses when intercellular communication is physically inhibited. Plans were created for the delivery of 8 Gy to the more radio-resistant DU-145 cells only in the presence and absence of intercellular communication. Cell survival was determined by clonogenic assay. In both cell lines, the out-of-field survival was not statistically different between delivery techniques for either cell line or dose. There was however, a statistically significant difference between survival out-of-field when intercellular communication was intact (single T80 culture flask) or inhibited (multiple T25 culture flasks) to in-field for all plans. No statistically significant difference was observed in-field with or without cellular communication to out-of-field for all plans. These data demonstrate out-of-field effects as important determinants of cell survival following exposure to modulated irradiation fields when cellular communication between differentially irradiated cell populations is present. This data is further evidence that refinement of existing radiobiological models to include indirect cell killing effects is required.

Mesh:

Year:  2012        PMID: 23022685     DOI: 10.1088/0031-9155/57/20/6635

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  8 in total

1.  Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy.

Authors:  Jeffrey S Souris; Shih-Hsun Cheng; Charles Pelizzari; Nai-Tzu Chen; Patrick La Riviere; Chin-Tu Chen; Leu-Wei Lo
Journal:  Appl Phys Lett       Date:  2014-11-20       Impact factor: 3.791

Review 2.  Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy.

Authors:  M Protopapa; V Kouloulias; A Kougioumtzopoulou; Z Liakouli; C Papadimitriou; A Zygogianni
Journal:  Clin Transl Oncol       Date:  2019-06-28       Impact factor: 3.405

3.  Cellular Damage in the Target and Out-Of-Field Peripheral Organs during VMAT SBRT Prostate Radiotherapy: An In Vitro Phantom-Based Study.

Authors:  Igor Piotrowski; Katarzyna Kulcenty; Wiktoria Suchorska; Marcin Rucinski; Karol Jopek; Marta Kruszyna-Mochalska; Agnieszka Skrobala; Piotr Romanski; Adam Ryczkowski; Dorota Borowicz; Natalia Matuszak; Julian Malicki
Journal:  Cancers (Basel)       Date:  2022-05-30       Impact factor: 6.575

4.  Treatment of breast cancer with simultaneous integrated boost in hybrid plan technique : Influence of flattening filter-free beams.

Authors:  Marzieh Bahrainy; Matthias Kretschmer; Vincent Jöst; Astrid Kasch; Florian Würschmidt; Jörg Dahle; Jörn Lorenzen
Journal:  Strahlenther Onkol       Date:  2016-03-14       Impact factor: 3.621

Review 5.  High dose bystander effects in spatially fractionated radiation therapy.

Authors:  Rajalakshmi Asur; Karl T Butterworth; Jose A Penagaricano; Kevin M Prise; Robert J Griffin
Journal:  Cancer Lett       Date:  2013-11-15       Impact factor: 8.679

6.  A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?

Authors:  Raffaella Marconi; Silvia Strolin; Gianluca Bossi; Lidia Strigari
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

7.  Use dose bricks concept to implement nasopharyngeal carcinoma treatment planning.

Authors:  Jia-Ming Wu; Tsan-Jung Yu; Shyh-An Yeh; Pei-Ju Chao; Chih-Jou Huang; Tsair-Fwu Lee
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

8.  Development of a quasi-humanoid phantom to perform dosimetric and radiobiological measurements for out-of-field doses from external beam radiation therapy.

Authors:  Marta Kruszyna-Mochalska; Agnieszka Skrobala; Piotr Romanski; Adam Ryczkowski; Wiktoria Suchorska; Katarzyna Kulcenty; Igor Piotrowski; Dorota Borowicz; Natalia Matuszak; Julian Malicki
Journal:  J Appl Clin Med Phys       Date:  2022-02-01       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.